Comparison of infarct volume and behavioral deficit in Wistar Kyoto and spontaneously hypertensive rat after transient occlusion of the middle cerebral artery by unknown
a SpringerOpen Journal
Garcia et al. SpringerPlus 2013, 2:414
http://www.springerplus.com/content/2/1/414RESEARCH Open AccessComparison of infarct volume and behavioral
deficit in Wistar Kyoto and spontaneously
hypertensive rat after transient occlusion of the
middle cerebral artery
Jorge Garcia, Jon Dang, Pardes Habib, Cordian Beyer† and Markus Kipp*†Abstract
Rodent models of focal cerebral ischemia are important tools in experimental stroke research. Such models have
proven instrumental for the understanding of injury mechanisms in cerebral stroke and helped to identify potential
new therapeutic options. A plethora of neuroprotective substances have been shown to be effective in preclinical
stroke research but failed to prove effectiveness in subsequent clinical trials. Interestingly, preclinical studies have
shown that neuroprotective agents are selectively effective in different rat strains. The underlying mechanisms for
this discrepancy are so far unknown, but differences in initial stroke volume with concomitant neuroinflammatory
processes in the expanding stroke area might be relevant.
In the current project, we compared the stroke volume and behavioral outcome between Wistar Kyoto (WKY) and
spontaneously hypertensive rats (SHR), subjected to transient middle cerebral artery occlusion (tMCAO) for 1 h,
followed by 23 h reperfusion. We further analyzed the expression of well-known pro-inflammatory mediators in the
cortical peri-infarct area region using a TTC-based isolation approach.
Initial reduction of local cerebral blood flow was comparable between both strains. Mean infarct volume and the
extent of tMCAO-provoked functional deficits did not differ between WKY and SHR rats. Furthermore, the induction
of pro-inflammatory mediators, among CCL3 and CCL5, in the isolated ischemic peri-infarct area region was equal
in both rat strains.
We were able to demonstrate that stroke outcome is comparable 23 h after transient MCAO in WKY and SHR rats.
Future studies have to show whether this observation confirms in the long-term, and which factors contribute to
differences observed with respect to therapeutic responsiveness.
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Cerebral stroke, also called cerebrovascular accident, is the
third leading cause of death and causes among the most
prevalent neurological diseases severe physical disability in
adulthood worldwide. Major risk factors for embolic stroke
are hypertension, age, nicotine abuse, dyslipidemia, and
Diabetes mellitus (Grau et al. 2001). Recombinant tissue
plasminogen activator (tPA) is the only approved medica-
tion in acute ischemic stroke (Group TNIoNDaSr-PSS* Correspondence: mkipp@ukaachen.de
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in any medium, provided the original work is p1995). However, less than 20% of all stroke patients receive
tPA which is mainly owed to the narrow treatment time
window of therapeutic success (Weimar et al. 2006).
Rodent models of focal cerebral ischemia are essential
tools in experimental stroke research. They have contrib-
uted significantly to our understanding of cell death mech-
anisms in stroke and helped to identify potential new
therapeutic strategies. A plethora of neuroprotective sub-
stances have been shown to be effective in preclinical
stroke research using animal models, but failed to exert
beneficial effects in subsequent clinical trials (Braeuninger
and Kleinschnitz 2009). Several factors may be responsible
for the failure of translation from bench to bedside. Theren Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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bolic differences between humans and small rodents,
which are the most common used experimental animals in
preclinical stroke research. Furthermore, preclinical stroke
studies are often restricted to juvenile male animals, al-
though it is evident that age significantly affects stroke out-
come (Davis et al. 1994, 1995; Duverger and MacKenzie
1988). Metabolic disturbances such as hypertension or
hypertriglyceridemia might also impact on stroke outcome
and might influence the effectiveness of any therapeutic
intervention. Interestingly, direct side-by-side comparison
of neuroprotective compounds revealed striking strain
differences in their potential to influence stroke out-
come. Porritt et al. (2010) for example demonstrated that
angiotensin-converting enzyme (ACE)-inhibition reduces
the infarct area in normotensive but not hypertensive rats.
In another study, 17beta-estradiol increased stroke dam-
age in normotensive rats with no significant effect in
stroke-prone rats (Carswell et al. 2004). Other variables
which make an interpretation of different studies difficult
include sex, age, and other comorbidities (Braeuninger
and Kleinschnitz 2009).
Preclinical anti-stroke drug development was often
conducted with the Wistar Kyoto (WKY) rat strain, but
stroke patients often suffer from metabolic disorders
and/or hypertension. Therefore, rats with comparable
metabolic stress might better mimic the human situ-
ation. Spontaneously hypertensive rats (SHR) share
many metabolic problems with essential hypertension
in humans and appear to be suited for a comparative
study. SHR rats have a genetic background of WKY
and suffer from early hypertension, hyperinsulinemia,
hypertriglyceridemia, and hypercholesteremia (Iritani et al.
1977; Swislocki and Tsuzuki 1993). Consequently, the
SHR strain recently is more frequently used in stroke
and cardiovascular research (Gow et al. 2011; Wang
et al. 2012).
In the current project we compared the stroke volume
and behavioral outcome between the two different rat
strains, i.e. WKY and SHR. Both were subjected to
tMCAO for 1 h, followed by a reperfusion of 23 h before
sacrification. Besides determining the infarct volume
and behavioral deficits, we analyzed the expression of
well-known pro-inflammatory mediators in the cortical
peri-infarct area region using TTC-based RNA isolation
(Dang et al. 2011; Kramer et al. 2010).
We were able to demonstrate that stroke outcome is
comparable 23 h after transient MCAO in WKY and
SHR rats.
Results
CBF course and infarct volume in WKY and SHR rats
To analyze the influence of disturbed cardio-vascular
and metabolic parameters for stroke outcome, tMCAOwas performed in WKY and SHR rats following the same
standardized protocol. Laser-Doppler monitoring re-
vealed that in all rats included in the study, regional
CBF values were reduced by >60% compared to pre-
ischemic values after induction of tMCAO and remained
stable during the entire occlusion period. As shown in
Figure 1A, no significant differences were observed in
the regional CBF between both strains. Mean values
dropped ~80% in SHR and ~68% in WKY compared to
baseline values. Furthermore, focal cerebral perfusion
remained at levels approx. 50% of the baseline during
the entire occlusion in both strains. Please note that
SHR show a slightly larger, but not significant drop of
CBF than WKY, nevertheless all animals remained at
CBF levels we previously determined as sufficiently low
for ischemic damage after experimental tMCAO.
In the next step, we investigated the infarct volume in
TTC-stained coronal brain sections 23 h after reperfu-
sion. TTC staining reliably delineated the infarct region
allowing to discriminate between the hypoxic-damaged
pale- compared to the surrounding red non-injured area.
Figure 1B depicts the morphological appearance of the
infarcted brain areas of two series of representative brain
slices corresponding to WKY and SHR rats subjected to
tMCAO. The lesion is confined in both strains to the
ipsilateral striatal region and the anterior and posterior
cerebral cortical vascular MCA territories as indicated
by the unstained pale area. Medial orientated cortical
areas, corresponding to the cingulated cortex (arrow-
head in Figure 1C) as well as the ipsilateral hippocampus
formation (arrow in Figure 1C) were not affected in both
rat strains. Subsequent quantification of the cortical in-
farct volume, corrected for edema formation, revealed
no significant differences between both strains, although
a slightly larger infarct volume is seen in SHR, which
might correlate with the larger drop of CBF in SHR. The
infarct volume was 141.85 ± 30.51 mm3 for WKY and
168.73 ± 21.54 mm3 for SHR.
Behavioral deficits in WKY and SHR rats
In addition to the parenchymal infarct damage, we eval-
uated stroke-induced functional impairments in both
strains after tMCAO. Besides spontaneous activity, dif-
ferent motor, coordination, and sensory aspects were
tested (see methods section). As shown in Figures 2A/B,
tMCAO significantly decreased the maximum scoring
from 18 points (sham-operated animals without tMCAO)
to ~9 in both rat strains. Not just that the overall behav-
ioral scoring declined to a comparable extent in WKY (8.9)
and SHR (8.0) animals (see Figure 2A), but scoring of all
subcategories was comparable as well, as demonstrated in
Figure 2B. Taken together, infarct volume and tMCAO-
related behavioral deficits are comparable in WKY and
SHR rat strains.
Figure 1 rCBF and cortical infarct volume. (A) Representative Laser-Doppler measurement of relative cerebral blood (rCBF) flow over the
ipsilateral middle cerebral artery territory before and during tMCAO (1 h). Reduction of rCBF is given as percentage of baseline values. (B) TTC-stained 2
mm coronal brain slices show the white infarct area 24 h after tMCAO. Red color indicates intact tissue. (C) Arrowhead indicates the cingulated cortex,
arrow the hippocampus. Quantitative data of the measurement of lesion volumes are given in (D). Note that lesion volumes are comparable in WKY
and SHR rat strains. Data represent means ± SEM. For further abbreviations see text.
Figure 2 Behavioral testing. (A/B) Results of behavioral testing of WKY and SHR rats 24 h after initiation of tMCAO. A total of six sub-tests were
performed resulting in a maximum of 18 scores in sham-operated animals (no tMCAO). Note that behavioral outcome is comparable in both rat
strains. Data represent means ± SEM. For further abbreviations see text. ***p< 0.001 sham compared to tMCAO.
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peri-infarct area of WKY and SHR rats
Under pathological and anatomical aspects, the peri-
infarct area is defined as the area surrounding an ischemic
event resulting from ischemic, thrombotic or embolic
stroke. A widely accepted definition for the peri-infarct
area is “ischemic tissue potentially destined for infarction
but not yet irreversibly injured and the target of acute
therapies” (Fisher and Bastan 2012). It has been shown
that differences exist in the architecture and composition
of the peri-infarct area between WKY and hyperten-
sive rat strains (Reid et al. 2012). This prompted us
to analyze in greater detail the expression levels of well-
defined pro-inflammatory mediators during stroke, namely
interleukin-6 (IL-6), CD68, CCL3 (MIP1α), and CCL5
(RANTES) by means of rt-PCR. As demonstrated in
Figure 3, the expression of all factors was significantly
induced and up-regulated in the peri-infarct area 23 h
post tMCAO. IL-6 and CD68 show a slightly higher
expression in SHR, but in accordance with the data
obtained for behavioral recovery and infarct spread,
no significant differences in expression levels were
found between WKY and SHR rats (p=0.18 for IL-6
and p=0.086 for CD68). Control experiments revealed
that no significant regulation of these factors is evi-
dent in the contra-lateral hemisphere compared to
sham-operated animals (data not shown).Figure 3 Gene expression in the peri-infarct area. Gene expression stud
tMCAO. (A) interleukin 6 expression, (B) CD68 expression, (C) chemokine (C
expression. Data represent means ± SEM. For further abbreviations see textDiscussion
Despite extensive animal research concerning the patho-
physiology of focal ischemic brain injury, no effective
translational treatment protocol emerged for stroke ther-
apy. A large number of neuroprotective agents have been
studied in the past such as free radical scavengers, excita-
tory amino acid antagonists, hypothermia, barbiturates,
calcium channel blockers or growth factors (Green 2008).
Many of these agents appeared protective or curative in
preclinical studies with small-animal models of ischemia
(rats, mice, or gerbils), but unfortunately none of these
have proven conclusively to be effective in humans (Green
2008; Savitz and Fisher 2007). An important critical aspect
is the choice of the appropriate animal model keeping
in mind that none would exactly mimic human stroke.
Many experimental studies used young WKY rats for
preclinical anti-stroke drug development (Dang et al.
2011; Melani et al. 2009; Ortega et al. 2012). However, the
“typical” stroke patient is elderly and suffers from several
co-morbidities such as hypertension, dyslipidemia et
cetera. In this study, we have compared the infarct
volume, behavioral deficit, and the expression of in-
flammatory markers in the peri-infarct area between
SHR and WKY animals during the initial infarct
period until 24 h after ischemia onset. Such a direct
comparison between both rat strains is important for our
understanding of stroke pathology and why neuroprotectiveies in tissue obtained from the cerebral cortex peri-infarct area after
-C motif) ligand 3 expression, (D) chemokine (C-C motif) ligand 5
.
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another.
Although, we have to emphasize that a tendency to-
wards a higher decline in rCBF and increased expression
of CD68 and IL6 was observed in SHR rats, our analysis
revealed that all tested parameters were similar in both
strains. According to the literature, certain rodent strains
are more sensitive to MCAO and produce more sizable
infarction volumes, whereas other strains produce only a
small infarction with MCAO (Takaba et al. 2004). For
example Hom et al. (2007) reported that SHR rats show
increased infarct volume following MCAO compared
with WKY rats. However, in contrast to the current
study protocol, they performed permanent MCAO and
infarct volumes were analyzed after a relatively short
period (4 h post occlusion) which significantly might im-
pact on the post-stroke outcome.
There is no doubt that significant differences exist be-
tween different rat strains that are commonly used dur-
ing preclinical stroke studies. SHR is a classical animal
model for studying hypertension, whereas stroke-prone
spontaneously hypertensive rat (SHRSP) are more fre-
quently used as spontaneous experimental model for
human stroke. Both SHR and SHRSP are hypertensive
animals, although SHRSP is more susceptible to stroke
as compared with SHR. In one study, gene expression
profiling in the brains of SHR and SHRSP was compara-
tively analyzed by gene chips. Of the 76 differentially
expressed genes under physiological conditions, 41 genes
were up-regulated, and 35 genes were down-regulated in
SHRSP as compared with SHR. One factor that showed
reduced expression in SHRSP rats was a riboflavin kin-
ase which was subsequently identified as a new potential
risk factor for stroke (Zou et al. 2012). In another study,
it has been demonstrated that E-selectin levels in brain
tissue and serum are significantly higher in SHRSP com-
pared to SHR rats after a high salt diet. The authors were
subsequently able to demonstrate that E-selectin defi-
ciency improves neurological behavior and reduces the in-
farction area after MCAO (Ma et al. 2012). Porritt et al.
(2010) were able to show that angiotensin-converting en-
zyme (ACE)-inhibition reduces infarction in normotensive
but not in hypertensive rats. WKY rats in the cited study
differed from SHR with respect to their marked cortical
ACE activity that is highly sensitive to ACE inhibition.
Interestingly, the beneficial effect of ACE inhibition on the
infarct volume in normotensive rats does not correlate
with changes in blood pressure. In another study, Carswell
et al. (2004) presented data that MCAO-induced brain
damage is reduced in SHRSP but not in normotensive
WKY rats during proestrus. Thus, a systematic compari-
son of different rat strains which differ with respect to
stroke development appears as a useful approach to iden-
tify candidate genes related to stroke pathophysiology.Besides behavioral outcome and stroke volume, we ana-
lyzed the expression of well described pro-inflammatory
mediators in the cortical peri-infarct area region using a
novel TTC-based isolation approach (Dang et al. 2011;
Kramer et al. 2010). We focused on such factors, i.e. IL-6,
CD68, CCL3 and CCL5, which have already been de-
scribed by us and others occurring in the ischemic peri-
infarct area and being relevant for tMCAO-induced brain
damage and post-stroke therapy (Benakis et al. 2012;
Bleilevens et al. 2013; Dang et al. 2011; Ginsberg 1997;
Kriz and Lalancette-Hebert 2009). We were able to show
that the magnitude and signature of gene expression up-
regulation is comparable within the peri-infarct area of
both rat strains, although we would like to emphasize that
there is a tendency to higher expression profiles of CD68
and IL-6 in SHR rats. Nevertheless, the similar outcome
of stroke volume, behavioral restoration, and important
pro-inflammatory markers suggest that there is no signifi-
cant difference with respect to short-term recovery be-
tween both rat strains. There are several important issues,
we would like to underline. First, we have no data
concerning the long-term outcome in both strains up to
1–2 weeks. It is well known that the infarct area has not
yet fully matured 24 hours post tMCAO (Neumann-
Haefelin et al. 2000) and it thus might be that differences
in stroke outcome become evident during later time
points. The same applies for functional deficits which
might become worse over time, as well. Second, animal
numbers used in this study are small and it might well be
that minor differences in stroke volume might be signifi-
cant if higher animal numbers were used. Third, in our
study we restricted our analysis to the cortex and did not
include subcortical regions such as the striatum. In a re-
cently published study we were able to demonstrate that
female sex steroids are able to protect cortical but not
sub-cortical areas after tMCAO in rats (Dang et al. 2011),
suggesting that cortical areas are more sensitive for
neuroprotective trial as subcortical areas are. Further-
more, it has been shown that functional test scores were
not distinguishable between sham-operated animals and
those with exclusive caudoputaminal infarcts (Wegener
et al. 2005) underpinning the importance of cortical areas
for post-stroke evaluation.
Conclusion
Nevertheless, our data convincingly demonstrate that
stroke outcome using the tMCAO model provides compar-
able values in WKY and SHR rats 23 h post reperfusion.
Methods
Animals
10–12 weeks old male WKY and 13–15 weeks old male
SHR (i.e. comparable weight) were purchased from
Charles River (Germany) and maintained according to
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Westphalia, Germany) in a pathogen free and climate-
controlled environment with free access to water and food
ad libitum. The Review Board for the Care of Animal
Subjects of the district government reviewed and ap-
proved the research and animal procedures. Behavioral
testing and infarct volume quantifications were performed
in a blinded manner. The experimenter was not aware of
the genetic background of the animal and animal from
both strains were randomly selected to avoid any external
influence on experimental outcome.
tMCAO and monitoring of cerebral blood flow
Most preclinical studies use the transient intraluminal
thread method for transient middle cerebral artery oc-
clusion (tMCAO) (Bleilevens et al. 2013; Dang et al.
2011; Ulbrich et al. 2012). This model was originally de-
veloped in rats, and has subsequently been modified
(Belayev et al. 1996; Chu et al. 2008) and adapted to
mice. In this model a monofilament is advanced via the
common or external carotid artery into the internal
carotid artery towards the division of the anterior and
middle cerebral arteries and thus occludes the middle
cerebral artery vascular territory. The filament may be
removed allowing for reperfusion (transient MCAO,
tMCAO) or may be left in place permanently (perman-
ent MCAO). The advantages of this technique are that it
models focal infarction in a large vascular territory with-
out craniotomy (Braeuninger and Kleinschnitz 2009).
In our experiments rats were subjected to general
anesthesia with 5% isoflurane (Abbott, Ludwigshafen,
Germany) for 2–3 min and maintained for further surgi-
cal steps at 2–2.5%. Body temperature was monitored
and maintained at 37°C ± 0.5°C using a rectal control
system coupled with a heating plate and infrared illu-
mination. Laser-Doppler measurement (Moor Instru-
ments, VMS-LDF2, Axminster, UK) of the local cerebral
blood flow (CBF) at the ipsi- and contralateral side was
used to assure a successful occlusion of the middle cere-
bral artery (MCA). For Laser-Doppler monitoring, the
skull was exposed and the sensors were positioned at
~1-2 mm posterior and ~4-5mm lateral of the bregma
(based on the highest blood perfusion units (BPU)).
tMCAO was performed as previously described (Dang
et al. 2011; Kramer et al. 2010; Ulbrich et al. 2012) with
minor modifications which were required due to minor
anatomical differences between both rat strains. Follow-
ing a small midline neck skin incision, the left common
carotid artery (CCA), internal carotid artery (ICA) and
external carotid artery (ECA) were exposed and the
vagal nerve was carefully separated from the CCA. Sub-
sequently, the ECA was mobilized, small arteries, includ-
ing the minor occipital artery were cauterized and finally
cut. After detaching the musculus omohyoideus from itstendinous origin, the ICA was mobilized until the origin
of the arteria pterygopalatina from the ICA was clearly
visible. Subsequently, the exposed arteria pterygopalatina
was ligated and mobilized by a filament to allow its
manipulation. The ECA was transiently clipped. Subse-
quently, the proximal CCA was permanently ligated, a
small incision in the CCA performed, and a commercially
available catheter (0,014'' Asahi PTCA Guide Wire Soft,
Abbott Vascular, Abbott Park, IL, USA) introduced into
the lumen of the CCA. The catheter was carefully pushed
cranially under visual control until the tip of the catheter
passed the origin of the arteria pterygopalatina. The head
was then bend aside and the catheter was gently pushed
further forward until a significant drop (>60% compared
to baseline values) of the local CBF occurred. After suc-
cessful occlusion of the MCA, the clipping of the ECA
was removed. After 1 h, the catheter was removed and the
CCA proximally and distally to the incision ligated.
Finally, the ligation of the arteria pterygopalatina was
released.
Sham-operated animals were subjected to the same
surgical steps, the catheter was not introduced into the
CCA.
Behavioral testing
A set of motor and sensory behavioral tests which are
commonly used to evaluate outcome in this model were
used to evaluate post-ischemic neurological deficits 23 h
after tMCAO (Garcia et al. 1995). The following 6 tests
were performed:
For analyzing spontaneous activity, the rat was placed in
an unfamiliar environment (35 cm × 55 cm sized cage)
and behavior was observed for 1 min. (3 = moving around,
exploring cage, and approaching at least 3 sides of the
cage; 2 = slightly affected, moving but hesitating to ex-
plore all the cage, still approaching at least one side of the
cage; 1 = obviously affected, slightly moving around but
not reaching any of the cage’s walls; 0 = not moving).
The outstretching of the forepaws was evaluated by
fixating the tail and comparing the outstretching of the
forelimbs (3 = symmetrical outstretching of both fore-
paws; 2 = less outstretching of the right side but still
moving both forelimbs; 1 = slight movement of the right
side; 0 = no movement of right forepaw).
To test the climbing ability, animals were placed on the
wall of a wire cage (3 = climbs and uses all four limbs and
grabbing wire tightly; 2 = climbing but with evident loss of
ability and power on right side; 1 = not climbing, not
holding to the wire, or circling instead of climbing).
Walking coordination and walking activity (3 = walking
straight ahead; 2 = not moving; 1 = walking to the right
side; 0 = circling right).
The sensory test for impaired proprioception was
performed by touching both sides of the rats with a blunt
Table 1 Primer sequences and annealing temperatures
(AT)
Gen Sequenz AT [°C]
HPRT s 5' - GGTCCATTCCTATGACTGTAGATTTT - 3' 60
as 5' - CAATCAAGACGTTCTTTCCAGTT - 3'
CD 68 s 5' - AATGTGTCCTTCCCACAAGC - 3' 60
as 5' - GGCAGCAAGAGAGATTGGTC - 3'
IL 6 s 5' - ACAGTGCATCATCGCTGTTC - 3' 60
as 5' - CCGGAGAGGAGACTTCACAG - 3'
CCL 2 s 5' - CCAGAAACCAGCCAACTCTC - 3' 58
as 5' - CCGACTCATTGGGATCATCT - 3'
CCL 5 s 5' - TGCCCACGTGAAGGAGTATTTTTA - 3' 60
as 5' - TGGCGGTTCCTTCGAGTGACAA - 3'
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side of the body (3 = turning the head and moving to side
of the stimulus, symmetrical reaction on both sides; 2 =
reacting but slowly to touch on right side; 1 = no response
to stimulus on right side).
Reaction to stimulus of the vibrissae was used to
complete the sensory testing (3 = turning head to side of
the stimulus symmetrically; 2 = reacting slowly to touch
on right side; 1 = no reaction to touch on right side).
After adding all individual test scores, a total max-
imum score of 18 and a minimum total score of 3 were
achievable.
TTC staining and quantification of infarct volume
23 h post-tMCAO, rats were sacrificed and transcardially
perfused with physiological NaCl. The brains were quickly
removed and placed in a cutting matrix (Alto Brain Matrix
stainless steel 1 mm rat coronal 300-600 g; Harvard
Apparatus, Holliston, MA, USA). Five coronal slices
with an individual thickness of 2 mm were cut and incu-
bated for 20 min in a 2% (w/v) TTC (2,3,5-triphenyl-
tetrazoliumchloride) solution prepared with physiological
NaCl. TTC has been shown to be a reliable marker for
metabolic active tissue because it is chemically reduced to
red TPF (1,3,5-triphenylformazan) in the presence of de-
hydrogenases (Altman 1976; Kramer et al. 2010). We used
TTC to delineate the ischemic core region from the peri-
infarct area and to assess the infarct volume. After the
TTC staining, slices were arranged in a frontal-occipital
orientation, and digital images were taken using a Canon
Digital IXUS 9015 Camera (Canon, Tokyo, Japan). The
freely available software ImageJ 1.44 p (NIH, Bethesda,
MD, USA) was used for the morphometric evaluation
of the infarct volume. The following equation was
used for infarct volume measurement and edema correc-
tion as published previously (Dang et al. 2011; Kramer
et al. 2010):
ipsilateral volume in mm3  infarct volume in mm3 =
contralateral volume in mm3
Genexpression analysis in the cortical peri-infarct area
region
In an ischaemic territory, irreversible damage progresses
over time from the center of the most severe flow reduc-
tion to the periphery with less disturbed perfusion. This
centrifugal progression of irreversible tissue damage is
characterized by a complex cascade of interconnected
electrophysiological, molecular, metabolic and perfusion
disturbances. This region is called ‘peri-infarct area’ and
was in the focus of our gene expression studies. Gene
expression studies were solely performed with tissues
corresponding to the peri-infarct area region defined inTTC-stained sections as published previously (Kipp et al.
2008; Dang et al. 2011; Kramer et al. 2010; Clarner et al.
2011). In brief, the cortical peri-infarct area was manually
dissected using a stereomicroscopic approach, dissolved in
lysis buffer (NucleoSpin_ RNA/Protein kit, Macherey-
Nagel, Germany), and homogenized with 1.4 mm diam-
eter ceramic beads (Precellys 24, Peqlab, Germany) at
5,000 rpm for 2 × 15 s. RNA was subsequently isolated
from this peri-infarct area tissue following a recently pub-
lished protocol (Dang et al. 2011). Purity was controlled
using 260:280 OD ratios (Nano- Drop 1000, Peqlab,
Germany). Gene expression was measured using the
RT-qPCR technology (BioRad, Germany), 2× SensiMix
Plus SYBR & Fluorescein (Quantace, Germany) and a
standardized protocol as described previously (Acs
et al. 2009; Braun et al. 2009; Baertling et al. 2010).
Relative quantification was performed using the ΔCt
method which results in ratios between target genes and
the housekeeping reference gene hypoxanthine guanine
phosphoribosyltransferase (HPRT). Melting curves and
gel electrophoresis of the PCR products were routinely
performed to determine the specificity of the PCR reac-
tion (data not shown). Primer sequences and individual
annealing temperatures are given in Table 1.
Statistical analysis
6 WKY and 10 SHR were included in infarct volume
measurements, 10 WKY and 10 SHR were included in
behavioral testing and 8 WKY and 8 SHR were included
in gene expression analyses. Statistics for infarct volume
and gene expression studies were performed using abso-
lute data. Intergroup differences were tested by one-way
ANOVA analysis and independent t-test using GraphPad
Prism 5 (GraphPad Software Inc.). For behavioral ana-
lyses, we performed the non-parametric Mann–Whitney
test. P-values are indicated as * = p ≤ 0.05, ** = p ≤ 0.01,
*** = p ≤ 0.001.
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